Treating Presbyphonia in 2024: A Scoping Review
- PMID: 39741021
- DOI: 10.1016/j.jvoice.2024.12.025
Treating Presbyphonia in 2024: A Scoping Review
Abstract
Presbyphonia is a multi-dimensional pathology. Therefore, its treatment should address its different affecting factors, including a global health management to fight geriatric frailty, improve overall physical strength, and limit medication side-effects. The specific therapies should address glottal gap closure and vocal folds' pliability. Based on a literature scoping review, we propose to start with voice therapy, combining different exercises and techniques that can improve voice quality. For patients with high vocal demands or larger glottal gaps, a medialization should be performed with an office-based medialization with hyaluronic acid injection as a first line. This can be associated with office-based injection of platelet rich plasma to improve mucosal vibration.
Keywords: Presbyphonia—Aging voice—Voice therapy—Medialization—Regenerative medicine..
Copyright © 2024 The Voice Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
